S Hsu, MD
Hematology · Visalia, CANPI 1912971300
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $724 and has fallen 76.3% since, to $171 in 2024. That places this record below the midpoint for hematology clinicians in CA, where the typical reported total is $4,615.
Across 96 payments — averaging $28.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$391
- Incyte Corporation$301
- Amgen$288
- Sanofi$238
- Gilead$151
- Genentech USA, Inc.$135
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,732100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 12 | $391 |
| Incyte Corporation | 7 | $301 |
| Amgen | 7 | $288 |
| Sanofi | 7 | $238 |
| Gilead | 2 | $151 |
| Genentech USA, Inc. | 2 | $135 |
| Daiichi Sankyo Inc. | 4 | $89 |
| Merck | 4 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Novartis | 4 | $77 |
| Exelixis Inc. | 1 | $76 |
| Sobi, Inc | 3 | $72 |
| Johnson & Johnson | 4 | $64 |
| Bayer | 4 | $56 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Astellas Pharma US Inc | 2 | $45 |
| Apellis Pharmaceuticals, Inc. | 2 | $44 |
| Morphosys, US Inc. | 2 | $43 |
| Deciphera Pharmaceuticals Inc. | 2 | $37 |
| Array Biopharma Inc | 2 | $37 |
| Tesaro, Inc. | 2 | $36 |
| Octapharma USA, Inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $29 |
| Dendreon Pharmaceuticals LLC | 1 | $25 |
| Seagen Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $24 |
| AVEO Pharmaceuticals, Inc. | 1 | $22 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $22 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| Pharmaessentia USA Corporation | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| Puma Biotechnology, Inc. | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $16 |
| Taiho Oncology, Inc. | 1 | $16 |
| BTG International Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,732 in reported general payments places this provider in the 45th percentile of 178 hematology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology in Visalia
- Everett MeyerStanford$2.1M
- Doris QuonLos Angeles$1.5M
- Amrita KrishnanDuarte$671K
- Ilene WeitzLos Angeles$631K
- Vinod PullarkatDuarte$576K
- Hope RugoSan Francisco$537K
- Alexey DanilovDuarte$407K
- Caroline PiatekLos Angeles$391K
- Deepu MadduriStanford$348K
- Tycel PhillipsDuarte$348K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.